Vaginal Gel

Description
Gel for prevention and coadjuvant treatment of injuries caused by papillomavirus (HPV).
- Create a defensive barrier that prevents the risk of HPV integration and the formation of new injuries.
- Helpful in the re-epitelization of the injuries already present.
- It stimulates the regeneration of the vaginal microbiota.
Papilocare is indicated for:
- control and help to re-epite the cervical transformation zone to prevent the risk of injury (LSIL) caused by HPV;
- the coadjuvant treatment of intraepitelial lesions caused by HPV;
- repair and help to summarize the lesions of the cervical-vaginal mucosa;
- to treat the dryness of the cervical-vaginal mucosa;
- rebalance the vaginal microbiota;
- improve vaginal health;
- create conditions for rapid healing of injuries caused by rubbing or itching;
- to form a protective film that quickly reduces the discomfort, creating conditions suitable to promote the natural process of scarring.
The main components of the formulation are:
- substances that allow the formation of a mucoadsive gel on the cervical-vaginal mucosa, creating, on the same, a protective film that favors the action of barrier of the product;
- hyaluronic acid niosomes, with moisturizing action of the tissues, which help preserve its elasticity;
- beta-glucan niosomes: thanks to their antioxidant properties, they maintain the structure and natural functionality of the skin and mucous membranes;
- phytosomes of Asian Centella, with repairing action of lesioned mucosa;
- Coriolus versicolor extract, with reepitalizing action and repairing of cervical and vaginal lesions and micro-lesions;
- neem extract, with emollient properties that favor the natural process of healing;
- BioEcolia, prebiotic that stimulates the growth of the beneficial bacterial flora and rebalances the microbiota in the cervico-vaginal area;
- extract of aloe vera with moisturizing action, reepitalizing and repairing of the cervical-vaginal area.
The use of Papilocare is recommended for positive (adult) women to papillomavirus (HPV), regardless of the presence of injuries caused by the virus (ASCUS or LSIL).

Mode of use
The duration of treatment is 6 months, with the possibility of further extending the period according to the prescription. It is important to complete the entire treatment cycle to obtain the expected results.
It is recommended to start treatment after the menstrual cycle.
First month: apply a cannula per day for 21 consecutive days, then suspend treatment in the next 7 days.
Later months (second to sixth): apply a cannula to alternate days for 21 days.
The suspension of treatment with Papilocare during the menstrual cycle is recommended only for the convenience of patients; there is no clinical incompatibility.
Apply preferably before bed.
It is compatible with the use of condom.
Remove any cannula that is open or broken. Cannula is designed to facilitate the administration of the product. Introduce the cannula into the vagina and exert pressure to release its content. Then extract the cannuòa from the vagina keeping it pressed so that it does not rehabilitate the produced product.
Within the cannula it may remain a bit of gel; this does not mean that a dose less than the recommended one has been delivered since the cannula frees enough to cover the cervical-vaginal mucosa (3 ml). Throw the cannula once used. Do not reuse a cannula already used or share it with other patients.

Warnings
Keep out of reach of children.
In case of pregnancy consult your doctor.
Do not use in case of hypersensitivity known to one of its components.
If after application you experience discomfort, suspend the use of the product and consult a doctor.
No data on the use of Papilocare together with contraceptives (e.g. vaginal ring or female condom) is available, so we do not recommend the use of Papilocare to women who are using this type of contraceptives. In case of pregnancy, consult your doctor before using Papilocare and use it under strict medical supervision.

Conservation
Store at temperature between 22°C and 25°C.
Validity of whole packaging: 42 months.

Format
Pack containing 21 cannulas of 5 ml.

Cod. 010/117